首页> 美国卫生研究院文献>Frontiers in Microbiology >Prevalence of Fosfomycin Resistance and Mutations in murA, glpT, and uhpT in Methicillin-Resistant Staphylococcus aureus Strains Isolated from Blood and Cerebrospinal Fluid Samples
【2h】

Prevalence of Fosfomycin Resistance and Mutations in murA, glpT, and uhpT in Methicillin-Resistant Staphylococcus aureus Strains Isolated from Blood and Cerebrospinal Fluid Samples

机译:从血液和脑脊液样本中分离出的耐甲氧西林金黄色葡萄球菌菌株对磷霉素的耐药性及其在murA,glpT和uhpT中的突变

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

In China, fosfomycin alone or in combination with other antibiotics is commonly used in the treatment of infections caused by Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA). Although fosfomycin-resistant S. aureus strains have continued to emerge and increase, the research on them is rare. In order to determine the prevalence and mechanisms of fosfomycin resistance in MRSA clinical isolates, a total of 96 non-duplicate MRSA isolates were collected from blood and cerebrospinal fluid samples at Huashan Hospital in Shanghai, China between 2004 and 2014. Antimicrobial susceptibility testing was performed by agar dilution. Meanwhile, the fosfomycin-resistance-related genes, fosB, murA, glpT, and uhpT, were amplified by PCR and subjected to sequencing analysis. Multilocus sequence typing (MLST) was conducted to assess strain types. The minimum inhibitory concentration (MIC) of fosfomycin for the 96 MRSA strains ranged from 1.0 to >1,024 mg/L, and approximately 70% (67/96) of the isolates were resistant to fosfomycin (MIC ≥ 64.0 mg/L). Nine isolates with MICs ≥ 128 mg/L carried fosB gene. Twenty-five distinct mutations were detected in the murA (7), glpT (10), and uhpT (8) genes. While five of the murA mutations and five of the glpT mutations were observed only in fosfomycin-sensitive isolates and one of the murA mutation was found both in fosfomycin-resistant and fosfomycin-sensitive isolates, the remaining 14 mutations (1 murA, 5 glpT, and all uhpT mutations) were present only in fosfomycin-resistant isolates. MLST analysis demonstrated that the majority (46/67) of the glpT and/or uhpT mutants belong to ST5, the predominant sequence type among the fosfomycin-resistant MRSA isolates. In conclusion, there is a high rate of fosfomycin resistance in MRSA strains. The mutations in the murA, glpT, and uhpT genes are common in fosfomycin-resistant MRSA strains, and may play a greater role in the development of fosfomycin resistance than the presence of the fosB gene in these organisms.
机译:在中国,单独使用磷霉素或与其他抗生素联合使用可治疗革兰氏阳性细菌(包括耐甲氧西林的金黄色葡萄球菌(MRSA))引起的感染。尽管抗草磷霉素的金黄色葡萄球菌菌株不断出现并增加,但对它们的研究却很少。为了确定MRSA临床分离株中磷霉素耐药的发生率和耐药机制,我们于2004年至2014年间从中国上海华山医院的血液和脑脊液样本中收集了96份非重复的MRSA分离株。进行了药敏试验通过琼脂稀释。同时,通过PCR扩增了与磷霉素抗性相关的基因fosB,murA,glpT和uhpT,并进行了测序分析。进行多基因座序列分型(MLST)以评估菌株类型。磷霉素对96株MRSA菌株的最低抑菌浓度(MIC)为1.0至> 1,024 mg / L,大约70%(67/96)的分离株对磷霉素具有抗药性(MIC≥64.0 mg / L)。 MIC≥128 mg / L的9个分离株带有fosB基因。在murA(7),glpT(10)和uhpT(8)基因中检测到25个不同的突变。虽然仅在对磷霉素敏感的菌株中观察到了5个murA突变和5个glpT突变,而在对磷霉素耐药的菌株和对磷霉素敏感的菌株中均发现了一个murA突变,其余14个突变(1个murA,5个glpT,和所有uhpT突变)仅存在于对磷霉素耐药的菌株中。 MLST分析表明,大多数(46/67)glpT和/或uhpT突变体属于ST5,即耐草磷霉素的MRSA分离株中的主要序列类型。总之,MRSA菌株对磷霉素的耐药率很高。在 murA,glpT uhpT 基因中的突变在耐草磷霉素的MRSA菌株中很常见,并且可能比在草甘膦耐药的情况下对草磷霉素的耐药性产生更大的作用。这些生物中的 fosB 基因。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号